ArticleForensic science, medicine, and pathology2026
Electric death: forensic pathological analysis and candidate biomarkers for forensic diagnosis.
Article in Forensic science, medicine, and pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Electrical injury is a severe multisystem trauma that is characterized by high clinical risk and mortality. For forensic practitioners, the diagnosis of electrocution death depends primarily on typical electric marks, scene investigations, and medical case information, which essentially constitute an exclusionary diagnostic procedure. Establishing a reliable diagnostic method for electrocution death, particularly in cases without visible electric marks, remains an urgent challenge in routine forensic practice. We retrospectively analyzed forensic electrocution death cases to screen novel molecular biomarkers for the diagnosis of mark‑absent electrocution death. Focusing on electric shock-induced malignant arrhythmia and cutaneous metal deposition, we detected the expression of oxidative stress‑sensitive genes in myocardial tissue and Cu²⁺‑dependent cuproptosis‑related genes in palmar skin. The Cu²⁺ concentration in palmar skin, combined with the expression levels of skin genes (e.g., FDX1 and CXCL6) and myocardial genes (e.g., GCLM and PRDX4), may serve as potential biomarkers for the auxiliary diagnosis of mark‑absent electrocution death. The combined detection of skin and myocardial samples provides a valuable auxiliary diagnostic strategy for challenging forensic cases.
Indexed as
Identifiers
42839205What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.